Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Govt. Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect

This article was originally published in The Pink Sheet Daily

Executive Summary

The development follows a relentless campaign launched over the last two years by the Indian Pharmaceutical Alliance, a powerful lobby of 17 large Indian companies.
Advertisement

Related Content

Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies
Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies
Not Selling Yet, Cipla Opposes Capping MNC-led Buyouts Of Indian Firms
India Story Tempered? Government May Put Future Brownfield Buyouts Under Scrutiny; No Qualms On Greenfield Investments
India's Health Minister Hits Out At Buyouts By Foreign Drug Makers; Are Investment Restrictions In The Cards?
Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical

Topics

Advertisement
UsernamePublicRestriction

Register

PS072874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel